Skip to content
Saturday 15 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE
MorningWire

European business, markets and politics

FTSE 100
10,750.11
-0.21%
DAX
26,440.31
+0.53%
CAC 40
8,636.80
-0.16%
STOXX 50
6,539.59
-0.09%
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
More
GermanyFranceBankingAIEnergyFintechPropertyCapital Markets
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
  • DE
Tuesday 04 December 2018 7:38 am  |  Updated:  Monday 03 June 2019 2:52 am

Marlboro-maker Altria is in talks to invest in Canadian cannabis producer Cronos

By: James Booth

Add as a preferred source on Google

The company behind Marlboro cigarettes is in talks to invest in a Canadian cannabis producer as it looks to cash in on the recent legalisation of the drug in Canada.

Altria is one of the world’s largest tobacco companies and the owner of the Marlboro brand.

Cannabis producer Cronos confirmed the talks after reports that Altria was set to acquire it.

Last night it said: “It is engaged in discussions concerning a potential investment by Altria Group in Cronos Group. No agreement has been reached with respect to any such transaction and there can be no assurance such discussions will lead to an investment or other transaction involving the companies.”

Any deal would mark one of the most significant investments in the cannabis sector by a traditional tobacco company.

Canada legalised recreational marijuana in October and legalised medicinal marijuana in 2001.

In June, London-based tobacco company Imperial Brands acquired a stake in Oxford Cannabinoid Technologies.

Constellation Brands announced a $3.8bn (£2.98bn) investment in Canopy Growth in August, while Coca-Cola said in September it was watching the space for alliances that could potentially help it develop products containing cannabinoid oil.

Altria’s shares have fallen by more than 20 per cent over the year, as cigarette smoking continues to decline in the United States. Federal data from earlier this month showed cigarette smoking among US adults reached an estimated 14 per cent in 2017, the lowest level ever.

Altria has invested in the e-cigarette sector in recent years through its Nu Mark subsidiary.

 

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • M&A

Trending Articles

  • Revolut takes flight with launch of new airport lounges

  • Grandparents fund university degrees to avoid inheritance tax net

  • Brompton Bicycle sues former adviser for ‘professional negligence’

  • Revolut chatbot goes rogue by charging users to cancel subscription

  • It’s not just Jason Arday, most of sociology is a scam

More from Morning Wire

  • Organigram Reports Record Third Quarter Fiscal 2026 Results

    Business Wire
  • Banning vape shops won’t fix scuzzy high streets

    Opinion
    High street vape shop Ecigwizard next to Costa Coffee and Subway, with people walking and sitting outside.
  • Government nationalises British Steel

    Industrials
    Britains steel industry facing challenges with potential shutdowns and job losses, highlighting economic impact.
  • Prologis pursuit of Segro descends into silver-haired scrap

    Property
    David Sleath, Chief Executive Officer, delivering a speech at a business conference with a focused expression.
  • Astrazeneca share price tumbles on $400bn megamerger talks

    Investing
    Astrazeneca headquarters with logo, reflecting commitment to reduce US medicine prices after Trump administration pressure
  • Revolut founder’s wealth set to balloon amid talks of share award at $500bn valuation

    Fintech
    Revolut CEO Nik Storonsky speaking at a business conference, wearing a suit and tie, addressing financial innovation.
  • QPR owner Bhatia Liverpool investment could value club at $6bn

    Sport Business
    Liverpool FC crest on a red brick wall, illuminated by sunlight with tree shadows.
  • Astrazeneca explores $400bn megadeal with US rival 

    Markets
    AstraZeneca building exterior with logo, glass facade, UK flag, and wildflowers in foreground.
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Business

  • Markets
  • Banking
  • Technology
  • Energy
  • Property
  • Fintech

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook